Measures of disability: Arthritis Impact Measurement Scales 2 (AIMS2), Arthritis Impact Measurement Scales 2-Short Form (AIMS2-SF), the Organization for Economic Cooperation and Development (OECD) Long-Term Disability (LTD) Questionnaire, EQ-5D, World Health Organization Disability Assessment Schedule II (WHODASII), Late-Life Function and

Arthritis Care and Research

Volumn 63, Issue SUPPL. 11, 2011, Pages

  Gignac, Monique A M ^a,b   Cao, Xingshan ^a   McAlpine, Jessica ^a   Badley, Elizabeth M ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTHRITIS; ARTHRITIS IMPACT MEASUREMENT SCALES 2; ARTHRITIS IMPACT MEASUREMENT SCALES 2 SHORT FORM; ARTICLE; ATTITUDE TO HEALTH; BATH; CLINICAL ASSESSMENT TOOL; CLOTHING; DAILY LIFE ACTIVITY; DEFECATION; DEMOGRAPHY; EATING; ENVIRONMENTAL FACTOR; EQ 5D; HEALTH STATUS; HOUSEHOLD; HUMAN RELATION; LATE LIFE FUNCTION AND DISABILITY INSTRUMENT; LATE LIFE FUNCTION AND DISABILITY INSTRUMENT ABBREVIATED VERSION; LEISURE; OSTEOARTHRITIS; PAIN ASSESSMENT; PERCEPTION; PHYSICAL DISABILITY; PSYCHOMETRY; QUALITY OF LIFE; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SHOPPING; SOCIAL ASPECT; SOCIAL INTERACTION; SOCIAL PARTICIPATION; SOCIETY; TASK PERFORMANCE; TEST RETEST RELIABILITY; THE ORGANIZATION FOR ECONOMIC COOPERATION AND DEVELOPMENT LONG TERM DISABILITY QUESTIONNAIRE; WORK; WORK DISABILITY; WORLD HEALTH ORGANIZATION DISABILITY ASSESSMENT SCHEDULE II;

AGE FACTORS; ARTHRITIS; DISABILITY EVALUATION; HUMANS; INTERNATIONAL COOPERATION; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SICKNESS IMPACT PROFILE; WORLD HEALTH ORGANIZATION;

EID: 80855144578     PISSN: 21514658     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/acr.20640     Document Type: Article

References (133)

1. World Health Organization. International classification of functioning, disability, and health. Geneva: World Health Orgaization; 2001.
2. Meenan RF, Mason JH, Anderson JJ, Guccione AA, Kazis LE,. AIMS2: the content and properties of a revised and expanded Arthritis Impact Measurement Scales Health Status Questionnaire. Arthritis Rheum 1992; 35: 1-10.
3. Guillemin F, Coste J, Pouchot J, Ghezail M, Bregeon C, Sany J, and the French Quality of Life in Rheumatology Group. The AIMS2-SF: a short form of the Arthritis Impact Measurement Scales 2. Arthritis Rheum 1997; 40: 1267-74. (Pubitemid 27430138)
4. Hagen KB, Smedstad LM, Uhlig T, Kvien TK,. The responsiveness of health status measures in patients with rheumatoid arthritis: comparison of disease-specific and generic instruments. J Rheumatol 1999; 26: 1474-80. (Pubitemid 29317867)
5. Hakala M, Nieminen P, Manelius J,. Joint impairment is strongly correlated with disability measured by self-reported questionnaires: functional status assessment of individuals with rheumatoid arthritis in a population based series. J Rheumatol 1994; 21: 64-9. (Pubitemid 24044920)
6. Salaffi F, Stancati A, Carotti M,. Responsiveness of health status measures and utility-based methods in patients with rheumatoid arthritis. Clin Rheumatol 2002; 21: 478-87. (Pubitemid 36054445)
7. Ten Klooster PM, Veehof MM, Taal E, van Riel PL, van de Laar MA,. Changes in priorities for improvement in patients with rheumatoid arthritis during 1 year of anti-tumour necrosis factor treatment. Ann Rheum Dis 2007; 66: 1485-90. (Pubitemid 350032657)
8. Rosemann T, Joos S, Laux G, Gensichen J, Szecsenyi J,. Case management of arthritis patients in primary care: a cluster-randomized controlled trial. Arthritis Rheum 2007; 57: 1390-7. (Pubitemid 350308835)
9. Husted J, Gladman DD, Farewell VT, Long JA,. Validation of the revised and expanded version of the Arthritis Impact Measurement Scales for patients with psoriatic arthritis. J Rheumatol 1996; 23: 1015-9. (Pubitemid 26196091)
10. Husted J, Gladman DD, Long JA, Farewell VT,. Relationship of the Arthritis Impact Measurements Scales (AIMS) to changes in articular status and functional performance in patients with psoriatic arthritis (PsA). J Rheumatol 1996; 23: 1923-37.
11. Long JA, Husted JA, Gladman DD, Farewell VT,. The relationship between patient satisfaction with health and clinical measures of function and disease status in patients with psoriatic arthritis. J Rheumatol 2000; 27: 958-66. (Pubitemid 30389754)
12. Taccari E, Spadaro A, Rinaldi T, Riccieri V, Sensi F,. Comparison of the Health Assessment Questionnaire and Arthritis Impact Measurement Scale in patients with psoriatic arthritis. Rev Rhum Eng Ed 1998; 65: 751-8. (Pubitemid 29030654)
13. Guillemin F, Challier B, Urlacher F, Vancon G, Pourel J,. Quality of life in ankylosing spondylitis: validation of the ankylosing spondylitis Arthritis Impact Measurement Scales 2, a modified Arthritis Impact Measurement Scales Questionnaire. Arthritis Care Res 1999; 12: 157-62. (Pubitemid 29508664)
14. Challier B, Urlacher F, Vancon G, Lemelle I, Pourel J, Guillemin F,. Is quality of life affected by season and weather conditions in ankylosing spondylitis? Clin Exp Rheumatol 2001; 19: 277-81. (Pubitemid 32529820)
15. Lukaczer D, Darland G, Tripp M, Liska D, Lerman RH, Schiltz B, et al. A pilot trial evaluating Meta050, a proprietary combination of reduced iso-alpha acids, rosemary extract and oleanolic acid in patients with arthritis and fibromyalgia. Phytother Res 2005; 19: 864-9. (Pubitemid 41670527)
16. Neumann L, Dudnik Y, Bolotin A, Buskila D,. Evaluation of a Hebrew version of the revised and expanded Arthritis Impact Measurement Scales (AIMS2) in patients with fibromyalgia. J Rheumatol 1999; 26: 1816-21. (Pubitemid 29367325)
17. Amadio PC, Silverstein MD, Ilstrup DM, Schleck CD, Jensen LM,. Outcome after Colles fracture: the relative responsiveness of three questionnaires and physical examination measures. J Hand Surg Am 1996; 21: 781-7. (Pubitemid 26374271)
18. Beeton K,. Evaluation of outcome of care in patients with haemophilia. Haemophilia 2002; 8: 428-34. (Pubitemid 35277169)
19. De Joode EW, van Meeteren NL, van den Berg HM, de Kleijn P, Helders PJ,. Validity of health status measurement with the Dutch Arthritis Impact Measurement Scale 2 in individuals with severe haemophilia. Haemophilia 2001; 7: 190-7. (Pubitemid 32243802)
20. Meeteren van NL, Strato IH, van Veldhoven NH, De Kleijn P, van den Berg HM, Helders PJ,. The utility of the Dutch Arthritis Impact Measurements Scales 2 for assessing health status with haemophilia; a pilot study. Haemophilia 2000; 6: 664-71.
21. Poiraudeau S, Dougados M, Ait-Hadad H, Pion-Graff J, Ayral X, Listrat V, et al. Evaluation of a quality of life scale (AIMS2) in rheumatology. Rev Rhum Ed Fr 1993; 60: 561-7.
22. McDowell I,. Measuring health: A guide to rating scales and questionnaires 2006. New York: Oxford University Press.
23. Brandao L, Ferraz MB, Zerbini CA,. Health status in rheumatoid arthritis: cross cultural evaluation of a Portuguese version of the Arthritis Impact Measurement Scales 2 (BRASIL-AIMS2). J Rheumatol 1998; 25: 1499-501. (Pubitemid 28364752)
24. Chu EM, Chiu KY, Wong RW, Tang WM, Lau CS,. Translation and validation of Arthritis Impact Measurement Scales 2 into Chinese: CAIMS2. Arthritis Rheum 2004; 51: 20-7. (Pubitemid 38222278)
25. Mousavi SJ, Parnianpour M, Askary-Ashtiani AR, Hadian MR, Rostamian A, Montazeri A,. Translation and validation study of the Persian version of the Arthritis Impact Measurement Scales 2 (AIMS2) in patients with osteoarthritis of the knee. BMC Musculoskelet Disord 2009; 10: 95.
26. Rosemann T, Szecsenyi J,. Cultural adaptation and validation of a German version of the Arthritis Impact Measurement Scales (AIMS2). Osteoarthritis Cartilage 2007; 15: 1128-33. (Pubitemid 47387054)
27. Spies-Dorgelo MN, Terwee CB, Stalman WA, van der Windt DA,. Reproducibility and responsiveness of the Symptom Severity Scale and the hand and finger function subscale of the Dutch arthritis impact measurement scales (Dutch-AIMS2-HFF) in primary care patients with wrist or hand problems. Health Qual Life Outcomes 2006; 4: 87.
28. Coulton CJ, Zborowsky E, Lipton J, Newman A,. Assessment of the reliability and validity of the arthritis impact measurement scales for children with juvenile arthritis. Arthritis Rheum 1987; 30: 819-24. (Pubitemid 17145220)
29. Hughes SL, Edelman P, Chang RW, Singer RH, Schuette P,. The GERI-AIMS: reliability and validity of the arthritis impact measurement scales adapted for elderly respondents. Arthritis Rheum 1991; 34: 856-65.
30. Atamaz F, Hepguler S, Oncu J,. Translation and validation of the Turkish version of the arthritis impact measurement scales 2 in patients with knee osteoarthritis. J Rheumatol 2005; 32: 1331-6.
31. Katz JN, Larson MG, Phillips CB, Fossel AH, Liang MH,. Comparative measurement sensitivity of short and longer health status instruments. Med Care 1992; 30: 917-25.
32. Meenan RF, Gertman PM, Mason JH,. Measuring health status in arthritis: the Arthritis Impact Measurement Scales. Arthritis Rheum 1980; 23: 146-52. (Pubitemid 10164319)
33. Meenan RF, Gertman PM, Mason JH, Dunaif R,. The Arthritis Impact Measurement Scales: further investigations of a health status measure. Arthritis Rheum 1982; 25: 1048-53. (Pubitemid 12028776)
34. Meenan RF,. New approaches to outcome assessment: the AIMS questionnaire for arthritis. Adv Intern Med 1986; 31: 167-85.
35. Haavardsholm EA, Kvien TK, Uhlig T, Smedstad LM, Guillemin F,. A comparison of agreement and sensitivity to change between AIMS2 and a short form of AIMS2 (AIMS2-SF) in more than 1,000 rheumatoid arthritis patients. J Rheumatol 2000; 27: 2810-6.
36. Ward MM, Kuzis S,. Validity and sensitivity to change of spondylitis-specific measures of functional disability. J Rheumatol 1999; 26: 121-7. (Pubitemid 29051407)
37. Taal E, Rasker JJ, Riemsma RP,. Sensitivity to change of AIMS2 and AIMS2-SF components in comparison to M-HAQ and VAS-pain. Ann Rheum Dis 2004; 63: 1655-8. (Pubitemid 39573698)
38. Husted JA, Gladman DD, Cook RJ, Farewell VT,. Responsiveness of health status instruments to changes in articular status and perceived health in patients with psoriatic arthritis. J Rheumatol 1998; 25: 2146-55. (Pubitemid 28505861)
39. Baillet A, Payraud E, Niderprim VA, Nissen MJ, Allenet B, Francois P, et al. A dynamic exercise programme to improve patients' disability in rheumatoid arthritis: a prospective randomized controlled trial. Rheumatology (Oxford) 2009; 48: 410-5.
40. Taylor LF, Kee CC, King SV, Ford TA,. Evaluating the effects of an educational symposium on knowledge, impact, and self-management of older African Americans living with osteoarthritis. J Community Health Nurs 2004; 21: 229-38. (Pubitemid 39577889)
41. Wetzels R, van Weel C, Grol R, Wensing M,. Family practice nurses supporting self-management in older patients with mild osteoarthritis: a randomized trial. BMC Fam Pract 2008; 9: 7.
42. Ren XS, Kazis L, Meenan RF,. Short-form Arthritis Impact Measurement Scales 2: tests of reliability and validity among patients with osteoarthritis. Arthritis Care Res 1999; 12: 163-71. (Pubitemid 29508665)
43. Ten Klooster PM, Veehof MM, Taal E, Van Riel PL, Van de Lar MA,. Confirmatory factor analysis of the Arthritis Impact Measurement Scales 2 Short Form in patients with rheumatoid arthritis. Arthritis Rheum 2008; 59: 692-8. (Pubitemid 351679545)
44. Rosemann T, Korner T, Wensing M, Schneider A, Szecsenyi J,. Evaluation and cultural adaptation of a German version of the AIMS2-SF questionnaire (German AIMS2-SF). Rheumatology (Oxford) 2005; 44: 1190-5. (Pubitemid 41236030)
45. Taal E, Rasker JJ, Riemsma RP,. Psychometric properties of a Dutch short form of the Arthritis Impact Measurement Scales 2 (Dutch-AIMS2-SF). Rheumatology (Oxford) 2003; 42: 427-34. (Pubitemid 36367533)
46. Rat AC, Guillemin F, Pouchot J,. Mapping the osteoarthritis knee and hip quality of life (OAKHQOL) instrument to the international classification of functioning, disability and health and comparison to five health status instruments used in osteoarthritis. Rheumatology (Oxford) 2008; 47: 1719-25.
47. Askary-Ashtiani AR, Mousavi SJ, Parnianpour M, Montazeri A,. Translation and validation of the Persian version of the Arthritis Impact Measurement Scales 2-Short Form (AIMS2-SF) in patients with rheumatoid arthritis. Clin Rheumatol 2009; 28: 521-7.
48. Wijilhuizen GJ, Ooijendijk W,. Measuring disability, the agreement between self evaluation and observation of performance. Disabil Rehabil 1999; 21: 61-7. (Pubitemid 29056132)
49. McDowell I,. Physical disability and handicap: the OECD long term disability questionnaire. In: Measuring health. A guide to ratings scales and questionnaires. New York: Oxford University Press; 2006. p. 93-5.
50. Wilson RW, McNeil JM,. Preliminary analysis of the OECD disability on the pretest of the post census disability survey. Rev Epidemiol Sante Publique 1981; 29: 469-75. (Pubitemid 12179812)
51. Badley EM, Rothman LM, Wang PP,. Modelling physical dependence in arthritis: the relative contribution of specific disabilities and environmental factors. Arthritis Care Res 1998; 11: 335-49.
52. Kaptein SA, Gignac MA, Badley EM,. Differences in the workforce experiences of women and men with arthritis disability: a population health perspective. Arthritis Rheum 2009; 61: 605-13.
53. Statistics Canada. Report of the Canadian Health and Disability Survey (STC 82-555E/F). Ottawa: Statistics Canada; 1986.
54. Statistics Canada. The 2006 participation and activity limitation survey: disability in Canada (c89-628-XIE). Ottawa: Minister of Industry; 2010.
55. Wang PP, Badley EM,. The contribution of arthritis and arthritis disability to non-participation in the labour force: a Canadian example. J Rheumatol 2001; 28: 1077-82. (Pubitemid 32422593)
56. The EuroQol Group. EuroQol: a new facility for the measurement of health-related quality of life. Health Policy 1990; 16: 199-208.
57. Hurst NP, Jobanputra P, Hunter M, Lambert M, Lochhead A, Brown H, et al. Validity of Euroqol, a generic health status instrument, in patients with rheumatoid arthritis. Br J Rheumatol 1994; 33: 655-62. (Pubitemid 24222119)
58. Hurst NP, Kind P, Ruta D, Hunter M, Stubbings A,. Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D). Br J Rheumatol 1997; 36: 551-9.
59. Janssen MF, Birnie E, Haagsma JA, Bonsel GJ,. Comparing the standard EQ-5D three-level system with a five-level version. Value Health 2008; 11: 275-84. (Pubitemid 351473607)
60. Fransen M, Edmonds J,. Reliability and validity of the EuroQol in patients with osteoarthritis of the knee. Rheumatology (Oxford) 1999; 38: 807-13. (Pubitemid 29507360)
61. Wolfe F, Kong SX, Watson DJ,. Gastrointestinal symptoms and health related quality of life in patients with arthritis. J Rheumatol 2000; 27: 1373-8. (Pubitemid 30354030)
62. Xie F, Li SC, Luo N, Lo NN, Yeo SJ, Yang KY, et al. Comparison of the EuroQol and short form 6D in Singapore multiethnic Asian knee osteoarthritis patients scheduled for total knee replacement. Arthritis Rheum 2007; 57: 1043-9. (Pubitemid 47237332)
63. Gordeev VS, Maksymowych WP, Evers SM, Ament A, Schachna L, Boonen A,. Role of contextual factors in health-related quality of life in ankylosing spondylitis. Ann Rheum Dis 2010; 69: 108-12.
64. Haywood KL, Garratt AM, Dziedzic K, Dawes PT,. Generic measures of health-related quality of life in ankylosing spondylitis: reliability, validity and responsiveness. Rheumatology (Oxford) 2002; 41: 1380-7. (Pubitemid 36004314)
65. Khanna D, Ahmed M, Yontz D, Ginsburg SS, Park GS, Leonard A, et al. The disutility of chronic gout. Qual Life Res 2008; 17: 815-22.
66. Duarte-Salazar C, Guzman-Vazquez S, Soto-Molina H, Chaidez-Rosales P, Ilizaliturri-Sanchez V, Nieves-Silva J, et al. Disability impact on quality of life in Mexican adults with juvenile idiopathic arthritis and juvenile ankylosing spondylitis. Clin Exp Rheumatol 2007; 25: 922-7. (Pubitemid 351166448)
67. Campbell H, Rivero-Arias O, Johnston K, Gray A, Fairbank J, Frost H,. Responsiveness of objective, disease-specific, and generic outcome measures in patients with chronic low back pain: an assessment for improving, stable, and deteriorating patients. Spine (Phila Pa 1976) 2006; 31: 815-22.
68. Garratt AM, Klaber Moffett J, Farrin AJ,. Responsiveness of generic and specific measures of health outcome in low back pain. Spine (Phila Pa 1976) 2001; 26: 71-7. (Pubitemid 32053055)
69. Aggarwal R, Wilke CT, Pickard AS, Vats V, Mikolaitis R, Fogg L, et al. Psychometric properties of the EuroQol-5D and Short Form-6D in patients with systemic lupus erythematosus. J Rheumatol 2009; 36: 1209-16.
70. Wolfe F, Michaud K, Li T, Katz RS,. EQ-5D and SF-36 quality of life measures in systemic lupus erythematosus: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, and fibromyalgia. J Rheumatol 2010; 37: 296-304.
71. Mease PJ, Woolley JM, Singh A, Tsuji W, Dunn M, Chiou CF,. Patient-reported outcomes in a randomized trial of etanercept in psoriatic arthritis. J Rheumatol 2010; 37: 1221-7.
72. Kievit W, Adang EM, Fransen J, Kuper HH, van de Laar MA, Jansen TL, et al. The effectiveness and medication costs of three anti-tumour necrosis factor α agents in the treatment of rheumatoid arthritis from prospective clinical practice data. Ann Rheum Dis 2008; 67: 1229-34.
73. Teng YK, Verburg RJ, Sont JK, van den Hout WB, Breedveld FC, van Laar JM,. Long-term followup of health status in patients with severe rheumatoid arthritis after high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation. Arthritis Rheum 2005; 52: 2272-6. (Pubitemid 41117409)
74. Van den Hout WB, de Jong Z, Munneke M, Hazes JM, Breedveld FC, Vliet Vlieland TP,. Cost-utility and cost-effectiveness analyses of a long-term, high-intensity exercise program compared with conventional physical therapy in patients with rheumatoid arthritis. Arthritis Rheum 2005; 53: 39-47. (Pubitemid 40216350)
75. Wolfe F, Michaud K,. The loss of health status in rheumatoid arthritis and the effect of biologic therapy: a longitudinal observational study. Arthritis Res Ther 2010; 12: R35.
76. Pipitone N, Scott DL,. Magnetic pulse treatment for knee osteoarthritis: a randomised, double-blind, placebo-controlled study. Curr Med Res Opin 2001; 17: 190-6. (Pubitemid 34003121)
77. Raman R, Dutta A, Day N, Sharma HK, Shaw CJ, Johnson GV,. Efficacy of Hylan G-F 20 and Sodium Hyaluronate in the treatment of osteoarthritis of the knee: a prospective randomized clinical trial. Knee 2008; 15: 318-24.
78. Boonen A, Patel V, Traina S, Chiou CF, Maetzel A, Tsuji W,. Rapid and sustained improvement in health-related quality of life and utility for 72 weeks in patients with ankylosing spondylitis receiving etanercept. J Rheumatol 2008; 35: 662-7. (Pubitemid 351500063)
79. Braun J, McHugh N, Singh A, Wajdula JS, Sato R,. Improvement in patient-reported outcomes for patients with ankylosing spondylitis treated with etanercept 50 mg once-weekly and 25 mg twice-weekly. Rheumatology (Oxford) 2007; 46: 999-1004. (Pubitemid 47062511)
80. Van Tubergen A, Boonen A, Landewe R, Rutten-Van Molken M, Van Der Heijde D, Hidding A, et al. Cost effectiveness of combined spa-exercise therapy in ankylosing spondylitis: a randomized controlled trial. Arthritis Rheum 2002; 47: 459-67. (Pubitemid 35291365)
81. Epps H, Ginnelly L, Utley M, Southwood T, Sculpher M, Woo P,. Is hydrotherapy cost-effective? A randomised controlled trial of combined hydrotherapy programmes compared with physiotherapy land techniques in children with juvenile idiopathic arthritis. Health Technol Assess 2005; 9: iii-iv, ix-x, 1-59.
82. Larsen K, Sorensen OG, Hansen TB, Thomsen PB, Soballe K,. Accelerated perioperative care and rehabilitation intervention for hip and knee replacement is effective: a randomized clinical trial involving 87 patients with 3 months of follow-up. Acta Orthop 2008; 79: 149-59. (Pubitemid 351878344)
83. Rolfson O, Dahlberg LE, Nilsson JA, Malchau H, Garellick G,. Variables determining outcome in total hip replacement surgery. J Bone Joint Surg Br 2009; 91: 157-61.
84. Barton GR, Sach TH, Avery AJ, Doherty M, Jenkinson C, Muir KR,. Comparing the performance of the EQ-5D and SF-6D when measuring the benefits of alleviating knee pain. Cost Eff Resour Alloc 2009; 7: 12.
85. Adams R, Walsh C, Veale D, Bresnihan B, FitzGerald O, Barry M,. Understanding the relationship between the EQ-5D, SF-6D, HAQ and disease activity in inflammatory arthritis. Pharmacoeconomics 2010; 28: 477-87.
86. Gulfe A, Kristensen LE, Saxne T, Jacobsson LT, Petersson IF, Geborek P,. Utility-based outcomes made easy: the number needed per quality-adjusted life year gained. An observational cohort study of tumor necrosis factor blockade in inflammatory arthritis from Southern Sweden. Arthritis Care Res (Hoboken) 2010; 62: 1399-406.
87. Huang IC, Willke RJ, Atkinson MJ, Lenderking WR, Frangakis C, Wu AW,. US and UK versions of the EQ-5D preference weights: does choice of preference weights make a difference? Qual Life Res 2007; 16: 1065-72. (Pubitemid 47174891)
88. Joore M, Brunenberg D, Nelemans P, Wouters E, Kuijpers P, Honig A, et al. The impact of differences in EQ-5D and SF-6D utility scores on the acceptability of cost-utility ratios: results across five trial-based cost-utility studies. Value Health 2010; 13: 222-9.
89. Kopec JA, Willison KD,. A comparative review of four preference-weighted measures of health-related quality of life. J Clin Epidemiol 2003; 56: 317-25. (Pubitemid 36593310)
90. Luo N, Johnson JA, Shaw JW, Coons SJ,. A comparison of EQ-5D index scores derived from the US and UK population-based scoring functions. Med Decis Making 2007; 27: 321-6. (Pubitemid 46801745)
91. Marra CA, Rashidi AA, Guh D, Kopec JA, Abrahamowicz M, Esdaile JM, et al. Are indirect utility measures reliable and responsive in rheumatoid arthritis patients? Qual Life Res 2005; 14: 1333-44. (Pubitemid 40895755)
92. McPherson K, Myers J, Taylor WJ, McNaughton HK, Weatherall M,. Self-valuation and societal valuations of health state differ with disease severity in chronic and disabling conditions. Med Care 2004; 42: 1143-51. (Pubitemid 39472121)
93. Wilke CT, Pickard AS, Walton SM, Moock J, Kohlmann T, Lee TA,. Statistical implications of utility weighted and equally weighted HRQL measures: an empirical study. Health Econ 2010; 19: 101-10.
94. Wolfe F, Michaud K, Wallenstein G,. Scale characteristics and mapping accuracy of the US EQ-5D, UK EQ-5D, and SF-6D in patients with rheumatoid arthritis. J Rheumatol 2010; 37: 1615-25.
95. Ravens-Sieberer U, Wille N, Badia X, Bonsel G, Burstrom K, Cavrini G, et al. Feasibility, reliability, and validity of the EQ-5D-Y: results from a multinational study. Qual Life Res 2010; 19: 887-97.
96. Luo N, Chew LH, Fong KY, Koh DR, Ng SC, Yoon KH, et al. Validity and reliability of the EQ-5D self-report questionnaire in English-speaking Asian patients with rheumatic diseases in Singapore. Qual Life Res 2003; 12: 87-92. (Pubitemid 36223009)
97. McPhail S, Lane P, Russell T, Brauer SG, Urry S, Jasiewicz J, et al. Telephone reliability of the Frenchay Activity Index and EQ-5D amongst older adults. Health Qual Life Outcomes 2009; 7: 48.
98. Brodszky V, Pentek M, Balint PV, Geher P, Hajdu O, Hodinka L, et al. Comparison of the Psoriatic Arthritis Quality of Life (PsAQoL) questionnaire, the functional status (HAQ) and utility (EQ-5D) measures in psoriatic arthritis: results from a cross-sectional survey. Scand J Rheumatol 2010; 39: 303-9.
99. Johnson JA, Pickard AS,. Comparison of the EQ-5D and SF-12 health surveys in a general population survey in Alberta, Canada. Med Care 2000; 38: 115-21.
100. Barton GR, Sach TH, Jenkinson C, Avery AJ, Doherty M, Muir KR,. Do estimates of cost-utility based on the EQ-5D differ from those based on the mapping of utility scores? Health Qual Life Outcomes 2008; 6: 51.
101. Kvamme MK, Kristiansen IS, Lie E, Kvien TK,. Identification of cutpoints for acceptable health status and important improvement in patient-reported outcomes, in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 2010; 37: 26-31.
102. Baron M, Schieir O, Hudson M, Steele R, Kolahi S, Berkson L, et al. The clinimetric properties of the World Health Organization disability assessment schedule II in early inflammatory arthritis. Arthritis Rheum 2008; 59: 382-90. (Pubitemid 351399209)
103. Van Tubergen A, Landewe R, Heuft-Dorenbosch L, Spoorenberg A, Van Der Heijde D, Van Der Tempel H, et al. Assessment of disability with the World Health Organisation Disability Assessment Schedule II in patients with ankylosing spondylitis. Ann Rheum Dis 2003; 62: 140-5. (Pubitemid 36135389)
104. Rehm J, Ustun TB, Shekhar S, Nelson CB, Chatterji S, Ivis F, et al. On the development and psychometric testing of the WHO screening instrument to assess disablement in the general population. Int J Methods Psychiatr Res 1999; 8: 110-22.
105. Ustun TB, Chatterji S, Kostanjsek N, Rehm J, Kennedy C, Epping-Jordan J, et al. Developing the World Health Organization Disability Assessment Schedule 2.0. Bull World Health Organ 2010; 88: 797-876.
106. Garin O, Ayuso-Mateos JL, Almansa J, Nieto M, Chatterji S, Vilagut G, et al. Validation of the "World Health Organiztion Disablility Assessment Scehdule, WHODAS-2" in patients with chronic diseases. Health Qual Life Outcomes 2010; 8: 51.
107. Kutlay S, Kucukdeveci AA, Elhan AH, Oztuna D, Koc N, Tennant A,. Validation of the World Health Organization disability assessment schedule II (WHODAS-II) in patients with osteoarthritis. Rheumatol Int 2011; 31: 339-46.
108. Posl M, Cieza A, Stucki G,. Psychometric properties of the WHODASII in rehabilitation patients. Qual Life Res 2007; 16: 1521-31. (Pubitemid 47566327)
109. Meesters JL, Verhoef J, Liem IS, Putter H, Vlieland TP,. Validity and responsiveness of the World Health Organization Disability Assessment Schedule II to assess disability in rheumatoid arthritis patients. Rheumatology (Oxford) 2010; 49: 326-33.
110. Hudson M, Steele R, Taillefer S, Baron M, and the Canadian Scleroderma Research Group. Quality of life in systemic sclerosis: psychometric properties of the World Health Organization Disability Assessment Schedule II. Arthritis Rheum 2008; 59: 270-8. (Pubitemid 351272965)
111. Noonan VK, Kopec JA, Noreau L, Singer J, Chan A, Masse LC, et al. Comparing the content of participation instruments using the International Classification of Functioning, Disability and Health. Health Qual Life Outcomes 2009; 7: 93.
112. Haley SM, Jette AM, Coster WJ, Kooyoomjian JT, Levenson S, Heeren T, et al. Late-Life Function and Disability Instrument II: development and evaluation of the function component. J Gerontol A Biol Sci Med Sci 2002; 57A: M217-22. (Pubitemid 34263298)
113. Jette AM, Haley SM, Coster WJ, Kooyoomjian JT, Levenson S, Heeren T, et al. Late-Life Function and Disability Instrument I: development and evaluation of the disability component. J Gerontol A Biol Sci Med Sci 2002; 57A: M209-16. (Pubitemid 34263297)
114. Jette AM, Haley SM, Ni P, Olarsch S, Moed R,. Creating a computer adaptive test version of the late-life function and disability instrument. J Gerontol A Biol Sci Med Sci 2008; 63: 1246-56. (Pubitemid 352772047)
115. McAuley E, Konopack JF, Motl RW, Rosengren K, Morriset KS,. Measuring disability and function in older women: psychometric properties of the Late-Life Function and Disability Instrument. J Gerontol A Biol Sci Med Sci 2005; 60A: 901-9. (Pubitemid 41098637)
116. Cutchin MP, Coppola S, Talley V, Svihula J, Catellie D, Shank KH,. Feasibility and effects of preventive home visits for at-risk older people: design of a randomized controlled trial. BMC Geriatrics 2009; 9: 54.
117. Gibson K, Day L, Hill KD, Jolley D, Newstead S, Cicuttini F, et al. Screening for pre-clinical disability in different residential settings. BMC Geriatr 2010; 10: 52.
118. Lenze EJ, Rollman BL, Shear MK, Dew MA, Pollock BG, Ciliberti C, et al. Escitalopram for older adults with generalized anxiety disorder (GAD): a randomized controlled trial. JAMA 2009; 301: 295-303.
119. Lowe SS, Watanabe SM, Baracos VE, Courneya KS,. Associations between physical activity and quality of life in cancer patients receiving palliative care: a pilot survey. J Pain Symptom Manage 2009; 38: 785-96.
120. Melzer I, Marx R, Kurz I,. Regular exercise in the elderly is effective to preserve the speed of voluntary stepping under single-task condition but not under dual-task condition: a case-control study. Gerontology 2009; 55: 49-57.
121. Ouellette MM, LeBrasseur NK, Bean JF, Phillips E, Stein J, Frontera WR, et al. High-intensity resistance training improves muscle strength, self-reported function, and disability in long-term stroke survivors. Stroke 2004; 35: 1404-9. (Pubitemid 38697466)
122. Karp JF, Skidmore E, Lotz M, Lenze E, Dew MA, Reynolds CF 3rd,. Use of the late-life function and disability instrument to assess disability in major depression. J Am Geriatr Soc 2009; 57: 1612-9.
123. Sayers SP, Jette AM, Haley SM, Heeren T, Guralnik JM, Fielding RA,. Validation of the Late-Life Function and Disability Instrument. J Am Geriatr Soc 2004; 52: 1554-9. (Pubitemid 39209607)
124. LaPier TK, Mizner R,. Outcome measures in cardiopulmonary physical therapy: focus on the Late-Life Function and Disability Instrument (LLFDI). Cardiopulm Phys Ther J 2009; 20: 32-5.
125. Dubuc N, Haley S, Ni P, Kooyoomjian J, Jette A,. Function and disability in late life: comparison of the Late-Life Function and Disability Instrument to the Short-Form-36 and the London Handicap Scale. Disabil Rehabil 2004; 26: 362-70. (Pubitemid 38468563)
126. Melzer I, Kurz I, Sarid O, Jette AM,. Relationship between self-reported function and disability and balance performance measures in the elderly. J Rehabil Res Dev 2007; 44: 685-91.
127. Hand C, Richardson J, Letts L, Stratford P,. Construct validity of the Late-Life Function and Disability instrument for adults with chronic conditions. Disabil Rehabil 2010; 32: 50-6.
128. Olarsch S,. Validity and responsiveness of the late-life function and disability instrument (LLFDI) in a facility-dwelling population [dissertation]. Boston: Boston University; 2008.
129. Denkinger MD, Weyerhauser K, Nikolaus T, Coll-Planas L,. Reliability of the abbreviated version of the Late-Life Function and Disability Instrument: a meaningful and feasible tool to assess physical function and disability in the elderly. Z Gerontol Geriatr 2009; 42: 28-38.
130. Denkinger MD, Igl W, Coll-Planas L, Bleicher J, Nikolaus T, Jamour M,. Evaluation of the short form of the late-life function and disability instrument in geriatric inpatients-validity, responsiveness, and sensitivity to change. J Am Geriatr Soc 2009; 57: 309-14.
131. Denkinger MD, Igl W, Jamour M, Bader A, Bailer S, Lukas A, et al. Does functional change predict the course of improvement in geriatric inpatient rehabilitation? Clin Rehabil 2010; 24: 463-70.
132. Hall K, McAuley E,. Individual, social environmental and physical environmental barriers to achieving 10,000 steps per day among older women. Health Educ Res 2010; 25: 478-88.
133. Motl RW, McAuley E, Suh Y,. Validity, invariance and responsiveness of a self-report measure of functional limitations and disability in multiple sclerosis. Disabil Rehabil 2010; 32: 1260-71.